BIO-TECHNE DECLARES DIVIDEND

Rhea-AI Summary

On February 2, 2023, Bio-Techne Corporation (NASDAQ: TECH) declared a quarterly dividend of $0.08 per share for the quarter ended December 31, 2022. This dividend will be payable on February 27, 2023 to shareholders of record on February 13, 2023. Bio-Techne, a global leader in life sciences, reported approximately $1.1 billion in net sales for fiscal 2022 and employs around 3,000 staff worldwide. The Board will evaluate future dividends quarterly. The company’s innovative tools and reagents play a critical role in research and diagnostics.

Positive

• Quarterly dividend of $0.08 per share enhances shareholder returns.
• Strong fiscal 2022 with $1.1 billion in net sales indicates robust performance.

Negative

• Potential risks highlighted in forward-looking statements may impact future operations.
• Dependence on ongoing product development efforts indicates vulnerability in execution.

MINNEAPOLIS, Feb. 2, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2022. The quarterly dividend will be payable February 27, 2023, to all common shareholders of record on February 13, 2023. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022 and has approximately 3,000 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio­ techne.com.

Forward Looking Statements:

Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. Forward looking statements in this press release include statements regarding potential future repurchase of Bio-Techne common stock. The following important factors, among others, have affected and, in the future, could affect the Company's actual results and future share price: the effect of new branding and marketing initiatives, the integration of new businesses and leadership, the introduction and acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, customer site closures or supply chain issues resulting from the COVID-19 pandemic, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships.

For additional information concerning such factors, see the section titled "Risk Factors" in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.

 

Contact:	David Clair, Vice President, Investor Relations
	David.Clair@bio-techne.co
	612-656-4416

 

 

 

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-declares-dividend-301737068.html

SOURCE Bio-Techne Corporation

FAQ

What is the dividend amount declared by Bio-Techne Corporation (TECH)?

Bio-Techne Corporation declared a dividend of $0.08 per share.

When will the dividend be paid to shareholders of Bio-Techne Corporation?

The dividend will be payable on February 27, 2023.

What date is the record for shareholders to receive the dividend from Bio-Techne Corporation?

Shareholders of record on February 13, 2023, will receive the dividend.

What were Bio-Techne Corporation's net sales for fiscal 2022?

Bio-Techne Corporation reported approximately $1.1 billion in net sales for fiscal 2022.

How often does Bio-Techne Corporation plan to declare dividends?

The Board of Directors will consider future cash dividends on a quarterly basis.